ARTICLE | Clinical News
Rexulti brexpiprazole regulatory update
October 10, 2016 7:00 AM UTC
FDA approved an sNDA from Otsuka for Rexulti brexpiprazole for maintenance treatment of schizophrenia in adults. Rexulti is also approved to treat schizophrenia and as an adjunct treatment for major d...